CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 20 enrolled
Drug / intervention
Active Osseointegrated Steady-State Implant System (OSI)device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04754477
NCT04754477N/ACompleted

A Multicentre, Open, Long-term Clinical Investigation Evaluating Safety, Performance and Patient Reported Outcomes With an Active Osseointegrated Steady-State Implant System in Adult Subjects With Conductive Hearing Loss, Mixed Hearing Loss or Single-sided Sensorineural Deafness.

Cochlear·interventional·Posted Feb 15, 2021·Updated Jun 10, 2024

In Brief

A clinical study evaluating Active Osseointegrated Steady-State Implant System (OSI) for Hearing Loss. Completed, enrolled 20 participants across 3 sites in 2 countries.

Detailed Summary

The aim of this clinical investigation is to collect long-term safety and performance data with the Active Osseointegrated Steady-State Implant System by following subjects from the previous Osia clinical investigation CBAS5751. In addition, questions regarding device satisfaction, sound satisfaction, usability and health care utilisation will be asked.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHearing Loss
CountriesAustralia, Hong Kong

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedFeb 15, 2021
Enrollment StartMay 6, 2021
Primary CompletionMar 21, 2022
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 5.4 years ago

Interventions

Active Osseointegrated Steady-State Implant System (OSI)device

System includes the OSI200 implant surgically placed under the skin behind the ear, the BI300 implant osseointegrated in the bone and the external Osia 2 sound process